Aurora-A overexpression leads to override of the microtubule-kinetochore attachment checkpoint
Stéphanie Dutertre1, Claude Prigent
1Groupe Cycle Cellulaire, UMR6061 CNRS-Université de Rennes 1, Faculté de Médecine, 2 Avenue du Pr Léon Bernard CS 34317, 35043 Rennes cedex, France. stephanie.dutertre@univ-rennes1.fr
Abstract:
The amplification of AURORA-A is frequently observed in specific epithelial cell malignancies. The overexpression of aurora-A, a Ser-Thr kinase known to localize to centrosomes during mitosis, appears to imbue cancerous cells with resistance to spindle-checkpoint-targeting drugs such as paclitaxel (Taxol). Indeed, a recent publication by Anand et al. indicates that overexpression of AURORA-A may interfere with spindle-microtubule attachment and disrupt the regulation of the spindle checkpoint by allowing cells with abnormal chromosomal separation to enter anaphase. Thus, the design of new drugs that specifically target aurora-A rather than other checkpoint proteins might alleviate the resistance to Taxol-like clinical therapeutics observed in some tumors.
Insights
Overexpression of AURORA-A kinase in cancer cells causes resistance to chemotherapy drugs like paclitaxel. Targeting AURORA-A may overcome this resistance, improving cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- AURORA-A kinase amplification is common in epithelial cancers.
- AURORA-A overexpression confers resistance to spindle-checkpoint inhibitors like paclitaxel.
- AURORA-A localizes to centrosomes during mitosis.
Purpose of the Study:
- To investigate the role of AURORA-A in cancer drug resistance.
- To explore AURORA-A as a potential therapeutic target.
Main Methods:
- Analysis of AURORA-A expression in epithelial malignancies.
- Review of existing literature on AURORA-A function and drug resistance (Anand et al.).
Main Results:
- AURORA-A overexpression disrupts spindle-microtubule attachment.
- This disruption leads to abnormal chromosomal separation and mitotic errors.
- Cells with abnormal mitosis enter anaphase due to faulty spindle checkpoint regulation.
Conclusions:
- Targeting AURORA-A specifically, rather than general checkpoint proteins, may be a viable strategy.
- Developing novel AURORA-A inhibitors could overcome paclitaxel resistance in tumors.
- This approach holds promise for improving the efficacy of existing cancer therapeutics.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Attachment of Sister Chromatids
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Anaphase Promoting Complex
DNA Damage Can Stall the Cell Cycle


